Is Adavosertib ready for sarcoma clinical trials? https://opa.uahs.arizona…
Is Adavosertib ready for sarcoma clinical trials?
UA Targeting Rhabdomyosarcoma, a Rare Pediatric Cancer With Few Treatment Options | UAHS Office of Public Affairs
Rhabdomyosarcoma (RMS) is a rare cancer of the skeletal muscle that primarily affects pediatric patients. After diagnosis, about 3 out of 4 patients are cured with standard treatment. Survival rates drop to 17 percent if the disease comes back (recurs) and to 30 percent if it spreads (metastasizes).